ArticleEuropean journal of case reports in internal medicine2025

Full Recovery Over One Year of the Overlap Syndrome Scleromyositis to Maintenance Therapy with Mycophenolate Mofetil and Rituximab, which Relapsed within 8 Months of Discontinuation.

Inês Amarante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.